NEW YORK, March 22, 2018 -- According to P&S Market Research, Intraoperative neuromonitoring market is forecasted to reach around $5.5 billion by 2023, the growth in the market will be led by the ageing population, increasing prevalence of chronic disorders, applications of IONM in different surgeries, and risk management through IONM during complex surgeries.
Request for Sample Pages: https://www.psmarketresearch.com/market-analysis/intraoperative-neuromonitoring-market/report-sample
In terms of product and services, the intraoperative neuromonitoring market has been categorized into systems, instruments, and accessories. The systems segment was the largest contributor to the global market, with more than 45% share in 2016.
The IONM applications involve spinal surgery, neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, and other surgeries. Among the available applications of IONM, orthopedic surgery is estimated to witness the fastest growth in demand at a CAGR of 7.9% during the forecast period. By end user, the intraoperative neuromonitoring market is led by hospitals contributing more than $2 billion in 2016. The large number of hospitals is the major factor to its large share in the market.
Asia-Pacific is the potential intraoperative neuromonitoring market for the growth of due to the high population base, presence of unmet medical needs, and increasing disposable incomes of people in the region. Moreover, the medical tourism and technological advancements make Asia-Pacific a lucrative market for IONM. It is estimated that the APAC will witness the fastest growth in demand at a CAGR of 8.6% during the forecast period.
Browse Full Report with detailed TOC on “Intraoperative Neuromonitoring Market” at: https://www.psmarketresearch.com/market-analysis/intraoperative-neuromonitoring-market
Key players in the intraoperative neuromonitoring industry are launching advanced products, to gain a larger market share. For instance, in February 2016, Nihon Kohden Corporation launched Neuromaster MEE-2000A, an IONM system, used in spine, neurology, vascular orthopedic, and otolaryngologic procedures. Similarly, in October 2016, Modberg Research Inc., launched CNS 300 monitor with wide screen display, high resolution, and advanced ICU amplifier.
Some of the other key players operating in the global intraoperative neuromonitoring market are Accurate Monitoring LLC, Computational Diagnostics, Inc., IntraNerve, LLC, Inomed Medizintechnik GmbH, Medtronic plc, and SpecialtyCare.
More Reports Published by P&S Market Research
Nerve Repair and Regeneration Market - https://www.psmarketresearch.com/market-analysis/nerve-repair-and-regeneration-market
Wearable Injectors Market - https://www.psmarketresearch.com/market-analysis/wearable-injectors-market
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: [email protected]
Web: https://www.psmarketresearch.com
Connect with us: LinkedIn | Twitter | Google + | Facebook


Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
Apple Restores Telegram to App Store After Content Policy Violation
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch
Jetstar to Charge for Overhead Cabin Bags From February
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
DeepSeek to Raise AI API Prices as Demand for New Models Surges
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management 



